Theriva Biologics (TOVX) Payables (2010 - 2026)
Theriva Biologics (TOVX) reported Payables of $984,000 for Q2 2026, up 62.1% from $607,000 a year earlier and up 61.8% from the prior quarter.
Powered by 
Analysis
Theriva Biologics (TOVX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Theriva Biologics posted Payables of $1.01 million, up 18.0% from FY2024.
- Payables has a five-year compound annual growth rate of 2.7% (FY2020 to FY2025).
- By year, Payables came in at $859,000 in FY2024 (+11.6%), $770,000 in FY2023 (-15.8%), $915,000 in FY2022 (+74.6%) and $524,000 in FY2021 (-40.9%).
- Five-year quarterly Payables spans a low of $437,000 in Q1 2025 and a high of $1.35 million in Q1 2022.
- Year over year, Payables has now increased in each of the last four quarters, with growth averaging 8.5% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q1 2022 (growth of 118.0%); the low point was Q1 2023 (a decline of 64.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $608,000 (Q1 2026), $1.01 million (Q4 2025) and $795,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Theriva Biologics | 9.71 Mn | -36.65 Mn | - | 984,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 984,000.00 |
| Mar 31, 2026 | 608,000.00 |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 795,000.00 |
| Jun 30, 2025 | 607,000.00 |
| Mar 31, 2025 | 437,000.00 |
| Dec 31, 2024 | 859,000.00 |
| Sep 30, 2024 | 756,000.00 |
| Jun 30, 2024 | 935,000.00 |
| Mar 31, 2024 | 571,000.00 |
| Dec 31, 2023 | 770,000.00 |
| Sep 30, 2023 | 833,000.00 |
| Jun 30, 2023 | 741,000.00 |
| Mar 31, 2023 | 480,000.00 |
| Dec 31, 2022 | 915,000.00 |
| Sep 30, 2022 | 770,000.00 |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 524,000.00 |
| Sep 30, 2021 | 1.26 Mn |
API Access
Theriva Biologics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=TOVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "TOVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=TOVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();